Clinical trial Recruiting at 7 sites Observational Ages 24 Hours to 18

Registry of long-term outcomes for children after cardiac arrest

Official title: Pediatric Resuscitation Neuroprognostication and Outcomes Registry

Run by Erasmus Medical Center · NCT06938009 · Data updated 2026-11-12

This study is looking at the long-term health and recovery of children in the Netherlands who have had a cardiac arrest to see how well they do after treatment.

More Cardiac Arrest (CA) trials

Quick facts

Study typeObservational
Ages24 Hours to 18 Years
SexAll
Enrollment500 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations7 sites (Nijmegen, Gelderland and 6 other locations)
StatusRecruiting
StartedJune 14, 2023
Main results expectedJanuary 2030
Study endsJanuary 2030
Registry record updatedApril 22, 2025
Trial IDNCT06938009 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children under 18 years old who have experienced cardiac arrest and received treatment in one of the participating academic hospitals in the Netherlands.

Probably not a fit

Patients who are neonates younger than 24 hours old or those who experienced cardiac arrest in a neonatal intensive care unit may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to gather data on the long-term outcomes of children in the Netherlands who experience cardiac arrest, whether in or out of the hospital. It will analyze survival rates, neurological outcomes, and the impact of emergency and post-resuscitation care on recovery. The study will collect routine medical records and follow patients through standard outpatient visits without requiring additional procedures. Data will be collected longitudinally at specified intervals to assess functional and neuropsychological outcomes over time.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies and better long-term outcomes for children who experience cardiac arrest.

How similar studies have gone: Other studies have shown success in similar observational approaches, but this specific registry focuses on pediatric cardiac arrest outcomes, making it a novel initiative.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients under the age of 18
* Experienced in-hospital or out-of-hospital cardiac arrest in the Netherlands
* Attended by emergency medical services or admitted to one of the seven participating Dutch academic pediatric hospitals
* Cardiac arrest defined as absence of palpable pulse or need for chest compressions lasting ≥1 minute
* Arrest managed under European Resuscitation Council guidelines (BLS/APLS)

Exclusion Criteria:

* Cardiac arrest occurring in neonates younger than 24 hours of age
* Cardiac arrest occurring in a neonatal intensive care unit (NICU) setting

Where it's running

  • Radboud umc
    Nijmegen, Gelderland, Netherlands
    Recruiting
  • Mumc
    Maastricht, Limburg, Netherlands
    Recruiting
  • Amsterdam UMC
    Amsterdam, North Holland, Netherlands
    Recruiting
  • Umcg
    Groningen, Provincie Groningen, Netherlands
    Recruiting
  • Lumc
    Leiden, South Holland, Netherlands
    Recruiting
  • Erasmus MC
    Rotterdam, South Holland, Netherlands
    Recruiting
Show 1 more location
  • Umcu
    Utrecht, Utrecht, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.